-
Signature
-
/s/ Carolyn Tang, Attorney-in-Fact
-
Issuer symbol
-
RCUS
-
Transactions as of
-
29 Sep 2025
-
Transactions value $
-
-$36,803
-
Form type
-
4
-
Filing time
-
30 Sep 2025, 18:59:03 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Azoy Alexander |
Chief Accounting Officer |
C/O ARCUS BIOSCIENCES, INC., 3928 POINT EDEN WAY, HAYWARD |
/s/ Carolyn Tang, Attorney-in-Fact |
30 Sep 2025 |
0001771961 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RCUS |
Common Stock |
Sale |
-$36.8K |
-2.83K |
-9.38% |
$13.00 |
27.4K |
29 Sep 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: